weight loss information
|
A Comparison of Sibutramine and Dexfenfluramine in the Treatment of ObesityBecause long-term weight reduction is often unsuccessful with dietary restriction alone, pharmacological agents have been used to promote weight loss. We have compared the novel (multiple monoamine neurotransmitter reuptake inhibitor) antiobesity drug sibutramine (10 mg once daily) with the extensively studied serotonin-releasing antiobesity agent dexfenfluramine (15 mg twice daily). 226 healthy outpatients (aged 18 to 65 years; body mass index > or =27 kg/m2) were included in a 12-week, randomized, double-blind, parallel group study. The main outcome measures were changes in weight, body mass index, waist and hip circumference and ratio, and safety profiles.
Sibutramine (10 mg once daily) is at least as effective as dexfenfluramine (15 mg twice daily) in achieving weight loss in patients with obesity. Source: Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P. Medical Direction,Laboratoires Knoll France-BASF Pharma. Articles About Weight Loss Drugs |
|